| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/31/2001 | EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof |
| 10/31/2001 | EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
| 10/31/2001 | EP0775157B1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 10/31/2001 | EP0719154B1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency |
| 10/31/2001 | EP0627918B1 New use of omega-3-fatty acids |
| 10/31/2001 | DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis |
| 10/31/2001 | CN1320125A Trizolopyridines for the treamtent of thrombosis disorders |
| 10/31/2001 | CN1320045A Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 10/31/2001 | CN1319594A Diazesuberane derivant or its salt |
| 10/31/2001 | CN1319419A Medicine for clinical emergency treatment of cerebral hemorrhage |
| 10/31/2001 | CN1073854C Tiandihua liquid for promoting hemopoiesis |
| 10/30/2001 | US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines |
| 10/30/2001 | US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors |
| 10/30/2001 | US6310065 Pyridazinone hydrochloride compound and method for producing the same |
| 10/30/2001 | US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72 |
| 10/30/2001 | US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 10/28/2001 | CA2345284A1 Blood pressure stabilization during hemodialysis |
| 10/25/2001 | WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 10/25/2001 | WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | WO2001079494A1 Agonist antibodies |
| 10/25/2001 | WO2001079480A1 Albumin fusion proteins |
| 10/25/2001 | WO2001079444A2 Albumin fusion proteins |
| 10/25/2001 | WO2001079443A2 Albumin fusion proteins |
| 10/25/2001 | WO2001079442A2 Albumin fusion proteins |
| 10/25/2001 | WO2001079288A2 Cytokine uses; compositions; methods |
| 10/25/2001 | WO2001079282A2 Molecules associated with human reproduction |
| 10/25/2001 | WO2001079271A1 Albumin fusion proteins |
| 10/25/2001 | WO2001079262A1 Pyrazinone and pyridinone derivatives as thrombin inhibitors |
| 10/25/2001 | WO2001079261A1 Tetrahydro-azepinone derivatives as thrombin inhibitors |
| 10/25/2001 | WO2001079260A1 Haemostatically active preparation containing vwf and method for the production thereof |
| 10/25/2001 | WO2001079258A1 Albumin fusion proteins |
| 10/25/2001 | WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 10/25/2001 | WO2001079158A2 Compounds for modulating cell proliferation |
| 10/25/2001 | WO2001079155A2 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 10/25/2001 | WO2001079153A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 10/25/2001 | WO2001078778A1 USE OF INHIBITION OF A Gas6 FUNCTION OR OF A Gas6 RECEPTOR FOR PREVENTING AND TREATING A CARDIOVASCULAR DISEASE |
| 10/25/2001 | WO2001078768A2 Targeted vaccine delivery systems |
| 10/25/2001 | WO2001078761A2 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors |
| 10/25/2001 | WO2001078755A2 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same |
| 10/25/2001 | WO2001078749A1 Novel calcium antagonists |
| 10/25/2001 | WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 10/25/2001 | WO2001078709A2 Treatment of neurodegenerative disease |
| 10/25/2001 | WO2001078688A1 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 10/25/2001 | WO2001078529A2 Compositions and methods for improving vascular health |
| 10/25/2001 | WO2001019798A3 Inhibitors of factor xa |
| 10/25/2001 | WO2001012790A3 Isomerase proteins |
| 10/25/2001 | WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof |
| 10/25/2001 | WO2000056737A9 Calanolides for inhibiting btk |
| 10/25/2001 | US20010034337 Antiproliferative agents |
| 10/25/2001 | US20010034331 Isolated polypeptide |
| 10/25/2001 | US20010033837 Mixture containing stabilizer |
| 10/25/2001 | US20010033834 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 10/25/2001 | DE10019062A1 Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia |
| 10/25/2001 | CA2747325A1 Albumin fusion proteins |
| 10/25/2001 | CA2407531A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 10/25/2001 | CA2406378A1 Targeted vaccine delivery systems |
| 10/25/2001 | CA2406245A1 Il-174 uses, compositions and methods |
| 10/25/2001 | CA2406160A1 Compounds for modulating cell proliferation |
| 10/25/2001 | CA2405709A1 Albumin fusion proteins |
| 10/25/2001 | CA2405701A1 Albumin fusion proteins |
| 10/25/2001 | CA2405684A1 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 10/25/2001 | CA2405563A1 Albumin fusion proteins |
| 10/25/2001 | CA2405557A1 Albumin fusion proteins |
| 10/25/2001 | CA2405550A1 Albumin fusion proteins |
| 10/25/2001 | CA2405525A1 Albumin fusion proteins |
| 10/25/2001 | CA2405451A1 Molecules associated with human reproduction |
| 10/25/2001 | CA2404858A1 Treatment of neurodegenerative disease |
| 10/25/2001 | CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 10/24/2001 | EP1148063A1 Composition containing hemostatic activ vWF and process for its preparation |
| 10/24/2001 | EP1147777A1 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
| 10/24/2001 | EP1147179A2 Human liver progenitors |
| 10/24/2001 | EP1147176A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 10/24/2001 | EP1147110A1 Pyrazino(aza)indole derivatives |
| 10/24/2001 | EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 10/24/2001 | EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors |
| 10/24/2001 | EP1146895A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 10/24/2001 | EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response |
| 10/24/2001 | EP1146885A1 Pre-conditioning against cell death |
| 10/24/2001 | EP1146874A1 Vitronectin receptor antagonist |
| 10/24/2001 | EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
| 10/24/2001 | CN1319133A Short peptides which selectively modulate activity of protein kinases |
| 10/24/2001 | CN1319096A Quinazoline derivatives and pharmaceutical applications thereof |
| 10/24/2001 | CN1319094A Imidazolyl derivatives |
| 10/24/2001 | CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 10/24/2001 | CN1319092A Benzamide derivatives and their use as cytokine inhibitors |
| 10/24/2001 | CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors |
| 10/24/2001 | CN1318412A Recipe and preparation process of hemopoietic capsule |
| 10/24/2001 | CN1318374A Preparation of Xinnaomaitong injecta for promoting blood circulation |
| 10/24/2001 | CN1073557C Vitamin-D amide derivatives |
| 10/24/2001 | CN1073430C 'Heilongzenghong' tablet for treatment of thrombosis |
| 10/23/2001 | US6307038 Nucleotide sequences coding fusion protein for use in treatment of oxidative stress |
| 10/23/2001 | US6307032 With von willebrand factor, comprising contacting composition with an immunoaffinity chromatography material, eluting complex with first elution buffer, eluting non-complexed factor viii or von willebrand factor with second buffer |
| 10/23/2001 | US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis |
| 10/23/2001 | US6306897 Calanolides for inhibiting BTK |
| 10/23/2001 | US6306886 Solid polymorph anticoagulants |
| 10/23/2001 | US6306884 Benzamidine derivatives and their use as anti-coagulants |
| 10/23/2001 | CA2085570C Pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/23/2001 | CA2049368C Treatment of cerebro-vascular disorders |